Korean Drug Market Cap

Korean Drug has a market cap or net worth of 43.10 billion as of March 9, 2026. Its market cap has decreased by -18.30% in one year.

Market Cap

43.10B

Enterprise Value

14.15B

Revenue

62.21B

Ranking

n/a

PE Ratio

15.44

Stock Price

3,825.00

Market Cap Chart

Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 43.10B, an increase of 243.72%. That is a compound annual growth rate of 6.07%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	41.74B	-11.05%
Dec 30, 2025	46.92B	-6.42%
Dec 30, 2024	50.14B	-36.00%
Dec 28, 2023	78.35B	-8.30%
Dec 29, 2022	85.44B	-12.32%
Dec 30, 2021	97.44B	-13.30%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GeneBioTech Co. ,Ltd	43.31B
HLscience	40.23B
Eagle Veterinary Technology Co.,Ltd	49.94B
Korea Arlico Pharm	50.20B
Kyung Nam Pharm	52.44B
RP Bio	57.20B
Jin Yang Pharmaceutical	58.29B
Seoul Pharma	30.72B

Market Cap Rankings